FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

VentureMed Group Appoints New CEO

Feb. 11, 2019
A A

VentureMed Group named Robert Paulson Jr. as its new chief executive officer as the company works to expand adoption of its FLEX VP endovascular system that prepares diseased peripheral arteries for treatment.

Paulson previously served as president and CEO at NxThera from 2009 until its acquisition by Boston Scientific in 2018.

Prior to that role, he served as president and CEO of Restore Medical, where he guided Medtronic’s 2008 acquisition.

View today's stories